Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (Parenthetical) - USD ($) $ in Thousands		3 Months Ended
		Sep. 30, 2023	Sep. 30, 2022
Total net revenue		$ 103,892	$ 96,493
Total cost of revenue	[1]	64,399	61,896
Research and development	[2]	14,013	14,092
Products
Total net revenue	[3]	53,350	44,623
Total cost of revenue		35,699	28,850
Services
Total net revenue	[4]	50,542	51,870
Total cost of revenue		28,700	33,046
Revenue from Joint Venture
Total cost of revenue		15,271	5,907
Research and development		132	779
Revenue from Joint Venture | Products
Total net revenue		21,952	8,869
Revenue from Joint Venture | Services
Total net revenue		$ 2,854	$ 2,957

[1] Includes cost of revenue from sales to the joint venture, an equity method investment, of $15,271 and $5,907 during the three months ended September 30, 2023 and 2022, respectively.

[2] Includes charge backs to the joint venture, an equity method investment, related to research and development of $132 and $779 during the three months ended September 30, 2023 and 2022, respectively.

[3] Includes sales of products to the joint venture, an equity method investment, of $21,952 and $8,869 during the three months ended September 30, 2023 and 2022, respectively. See Note 13.

[4] Includes sales of services to the joint venture, an equity method investment, of $2,854 and $2,957 during the three months ended September 30, 2023 and 2022, respectively, See Note 13.